News provided by Novo Nordisk Nov 17, 2025, 07:45 ET For a limited time, patients in the US can get the first two doses of authentic, FDA-approved Wegovy and Ozempic for only $199 each beginning November 17, 2025 Also effective November 17, Novo Nordisk is lowering the price of Wegovy and Ozempic for existing self-pay patients in the US from $499 to $349 per month* Self-pay pricing available through 70,000+ pharmacies nationwide, home delivery, and select telehealth providers These offers build on Novo Nordisk's ongoing efforts to expand access to FDA-approved semaglutide medicines across the many different channels patients use to get their prescriptions PLAINSBORO, N.J., Nov
, , ,
n = 4 patients with PD), TMS ( n = 36 patients with PD), MRgFUS ( n = 10 patients with PD) and levodopa challenge test (LCT dataset: n = 21 patients with PD) with RSFC precision functional mapping 40,41,42,43,44,45,46,47 and ECoG recordings
We respond within 24 hours with the COA PDF attached